| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2011 | Acetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitors. | Song, H; Li, CW ; Labaff, AM; Lim, SO; Li, LY; Kan, SF; Chen, Y; Zhang, K; Lang, J; Xie, X; Wang, Y; Huo, LF; Hsu, SC; Chen, X; Zhao, Y; Hung, MC | Biochemical and biophysical research communications 404(1), 68-73 | | | |
| 2016 | AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation. | Li, CW ; Xia, W; Lim, SO; Hsu, JL; Huo, L; Wu, Y; Li, LY; Lai, CC; Chang, SS; Hsu, YH; Sun, HL; Kim, J; Yamaguchi, H; Lee, DF; Wang, H; Wang, Y; Chou, CK; Hsu, JM; Lai, YJ; LaBaff, AM; Ding, Q; Ko, HW; Tsai, FJ; Tsai, CH; Hortobagyi, GN; Hung, MC | Cancer research 76(6), 1451-1462 | | | |
| 2018 | Deglycosylation of PD-L1 by 2-deoxyglucose reverses PARP inhibitor-induced immunosuppression in triple-negative breast cancer. | Shao, B; Li, CW; Lim, SO; Sun, L; Lai, YJ; Hou, J; Liu, C; Chang, CW; Qiu, Y; Hsu, JM; Chan, LC; Zha, Z; Li, H; Hung, MC | American journal of cancer research 8(9), 1837-1846 | | | |
| 2016 | Deubiquitination and Stabilization of PD-L1 by CSN5. | Lim, SO; Li, CW ; Xia, W; Cha, JH; Chan, LC; Wu, Y; Chang, SS; Lin, WC; Hsu, JM; Hsu, YH; Kim, T; Chang, WC; Hsu, JL; Yamaguchi, H; Ding, Q; Wang, Y; Yang, Y; Chen, CH; Sahin, AA; Yu, D; Hortobagyi, GN; Hung, MC | Cancer cell 30(6), 925-939 | | | |
| 2019 | Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade. | Zhu, Y; Yang, J; Xu, D; Gao, XM; Zhang, Z; Hsu, JL; Li, CW ; Lim, SO; Sheng, YY; Zhang, Y; Li, JH; Luo, Q; Zheng, Y; Zhao, Y; Lu, L; Jia, HL; Hung, MC; Dong, QZ; Qin, LX | Gut 68(9), 1653-1666 | | | |
| 2016 | EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape. | Lim, SO; Li, CW ; Xia, W; Lee, HH; Chang, SS; Shen, J; Hsu, JL; Raftery, D; Djukovic, D; Gu, H; Chang, WC; Wang, HL; Chen, ML; Huo, L; Chen, CH; Wu, Y; Sahin, A; Hanash, SM; Hortobagyi, GN; Hung, MC | Cancer research 76(5), 1284-1296 | | | |
| 2012 | Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1. | Li, CW ; Xia, W; Huo, L; Lim, SO; Wu, Y; Hsu, JL; Chao, CH; Yamaguchi, H; Yang, NK; Ding, Q; Wang, Y; Lai, YJ; LaBaff, AM; Wu, TJ; Lin, BR; Yang, MH; Hortobagyi, GN; Hung, MC | Cancer research 72(5), 1290-1300 | | | |
| 2018 | Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1. | Li, CW; Lim, SO; Chung, EM; Kim, YS; Park, AH; Yao, J; Cha, JH; Xia, W; Chan, LC; Kim, T; Chang, SS; Lee, HH; Chou, CK; Liu, YL; Yeh, HC; Perillo, EP; Dunn, AK; Kuo, CW; Khoo, KH ; Hsu, JL; Wu, Y; Hsu, JM; Yamaguchi, H; Huang, TH; Sahin, AA; Hortobagyi, GN; Yoo, SS; Hung, MC | Cancer cell 33(2), 187-201.e10 | | | |
| 2016 | Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. | Li, CW ; Lim, SO; Xia, W; Lee, HH; Chan, LC; Kuo, CW; Khoo, KH ; Chang, SS; Cha, JH; Kim, T; Hsu, JL; Wu, Y; Hsu, JM; Yamaguchi, H; Ding, Q; Wang, Y; Yao, J; Lee, CC; Wu, HJ; Sahin, AA; Allison, JP; Yu, D; Hortobagyi, GN; Hung, MC | Nature communications 7, 12632 | | | |
| 2016 | GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers. | Ko, HW; Lee, HH; Huo, L; Xia, W; Yang, CC; Hsu, JL; Li, LY; Lai, CC; Chan, LC; Cheng, CC; Labaff, AM; Liao, HW; Lim, SO; Li, CW ; Wei, Y; Nie, L; Yamaguchi, H; Hung, MC | Oncotarget 7(35), 57131-57144 | | | |
| 2018 | Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1. | Cha, JH; Yang, WH; Xia, W; Wei, Y; Chan, LC; Lim, SO; Li, CW; Kim, T; Chang, SS; Lee, HH; Hsu, JL; Wang, HL; Kuo, CW; Chang, WC; Hadad, S; Purdie, CA; McCoy, AM; Cai, S; Tu, Y; Litton, JK; Mittendorf, EA; Moulder, SL; Symmans, WF; Thompson, AM; Piwnica-Worms, H; Chen, CH; Khoo, KH ; Hung, MC | Molecular cell 71(4), 606-620.e7 | | | |
| 2017 | PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression. | Jiao, S; Xia, W; Yamaguchi, H; Wei, Y; Chen, MK; Hsu, JM; Hsu, JL; Yu, WH; Du, Y; Lee, HH; Li, CW ; Chou, CK; Lim, SO; Chang, SS; Litton, J; Arun, B; Hortobagyi, GN; Hung, MC | Clinical cancer research : an official journal of the American Association for Cancer Research 23(14), 3711-3720 | | | |
| 2017 | Rational combination of immunotherapy for triple negative breast cancer treatment. | Li, CW ; Lim, SO; Hsu, JL; Hung, MC | Chinese clinical oncology 6(5), 54 | | | |
| 2018 | STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion. | Hsu, JM; Xia, W; Hsu, YH; Chan, LC; Yu, WH; Cha, JH; Chen, CT; Liao, HW; Kuo, CW; Khoo, KH ; Hsu, JL; Li, CW; Lim, SO; Chang, SS; Chen, YC; Ren, GX; Hung, MC | Nature communications 9(1), 1908 | | | |
